✦ LIBER ✦

Phase I trial of 5-fluorouracil by 24-hour infusion weekly

✍ Scribed by N. B. Haas; J. B. Hines; G. R. Hudes; N. Johnston; R. F. Ozols; P. J. O'Dwyer

Publisher: Springer US
Year: 1993
Tongue: English
Weight: 397 KB
Volume: 11
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00874152

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of ilmofosine as a 24 hour

Phase I trial of ilmofosine as a 24 hour infusion weekly

✍ M. Mehren; B. J. Giantonio; C. McAleer; R. Schilder; J. McPhillips; P. J. O'Dwye 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 491 KB

A simplified regimen of weekly high dose

A simplified regimen of weekly high dose 5-fluorouracil and leucovorin as a 24-hour infusion in patients with advanced colorectal carcinoma

✍ Tsai-Shen Yang; Kuan-Cheng Hsu; Jy-Ming Chiang; Reiping Tang; Jinn-Shium Chen; C 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

## BACKGROUND. Reports of in vitro experiments in colorectal carcinoma cells suggest that prolonged cellular exposure to 5-fluorouracil (5-FU) combined with relatively low concentrations of leucovorin (LV) provides optimal enhancement of 5-FU efficacy. In this study, a simplified regimen of weekly

A phase I trial of 5-fluorouracil, leuco

A phase I trial of 5-fluorouracil, leucovorin, and dipyridamole given by concurrent 120-h continuous infusions

✍ Howard Bailey; George Wilding; Kendra D. Tutsch; Rhoda Z. Arzoomanian; Dona Albe 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 703 KB

Phase I study of protracted venous infus

Phase I study of protracted venous infusion of 5-fluorouracil

✍ J. Lokich; A. Bothe; N. Fine; J. Perri 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

Phase I and pharmacokinetic study of KW-

Phase I and pharmacokinetic study of KW-2149 given by 24 hours continuous infusion

✍ Luc Dirix; Gilles Catimel; René Verdonk; Ernst Bruijn; Brigitte Tranchand; Claud 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 334 KB

A phase II trial of weekly high dose con

A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer

✍ Enrique Aranda; Andrés Cervantes; Javier Dorta; Esperanza Blanco; Carlos Fernánd 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer